Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 11
Original Research
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,556 | Dovepress* | 8,790+ | 1,561 | 10,351 | |
| PubMed Central* | 1,766 | 671 | 2,437 | ||
| Totals | 10,556 | 2,232 | 12,788 | ||
| *Since 27 November 2018 | |||||
View citations on PubMed Central and Google Scholar